Safety, Efficacy, and Feasibility of Nebulized Long-Acting Bronchodilators vs Short-Acting Bronchodilators in Hospitalized Patients With Acute Exacerbations of COPD: A Phase IV, Randomized, Parallel-Group Clinical Trial.

CHEST Pulm · 2024 · PMC13418693 · PMID 42548489

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a nonsignificant trendP = .08so close (0.05 < p ≤ 0.1)

Patients receiving formoterol/revefenacin had similar Modified Borg dyspnea scores ( P = .95) and required fewer total drug doses ( P < .001), but there was a nonsignificant trend for more frequent rescue treatments ( P = .08) compared with those receiving albuterol/ipratropium.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.